Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - Inspire Medical Systems, Inc. | a202010kex32-2.htm |
| EX-32.1 - EX-32.1 - Inspire Medical Systems, Inc. | a202010kex32-1.htm |
| EX-31.2 - EX-31.2 - Inspire Medical Systems, Inc. | a202010kex31-2.htm |
| EX-31.1 - EX-31.1 - Inspire Medical Systems, Inc. | a202010kex31-1.htm |
| EX-21.1 - EX-21.1 - Inspire Medical Systems, Inc. | a202010kex21-1.htm |
| EX-10.20 - EX-10.20 - Inspire Medical Systems, Inc. | exhibit1020bryanphillips.htm |
| EX-10.13 - EX-10.13 - Inspire Medical Systems, Inc. | exhibit10-13rsuagreement.htm |
| 10-K - 10-K - Inspire Medical Systems, Inc. | insp-20201231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements on Form S-3 No.333-237654 and Form S-8 No. 333-224731 pertaining to the Inspire Medical Systems, Inc. 2018 Incentive Award Plan, the Inspire Medical Systems, Inc. 2007 Stock Incentive Plan, as amended, the Inspire Medical Systems, Inc. 2017 Stock Incentive Plan, as amended, and the Inspire Medical Systems, Inc. 2018 Employee Stock Purchase Plan, of our reports dated February 23, 2021, with respect to the financial statements of Inspire Medical Systems, Inc., and the effectiveness of internal control over financial reporting of Inspire Medical Systems, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2020.
/s/ Ernst & Young LLP
Minneapolis, Minnesota
February 23, 2021